These mechanisms might explain the reasons why the paclitaxel-induced spinal iPLA2 and cPLA2 activation and subsequent LPA production are delayed as compared with the case of peripheral nerve injury. The gene discussed is PLA2G6; the disease is peripheral nerve injury.